-
A New Generation of Drug Therapies Requires New Business Strategies
Operations and supply chain management Digital ArticleThe shift toward advanced therapeutic modalities will require life sciences companies to rethink strategy, investments, and risk management. -
Moderna v. Pfizer: What the Patent Infringement Suit Means for Biotech
Business and society Digital ArticleAfter an unusual period of cooperation, drug companies are suing each other again. -
A Debt of Gratitude
Management Magazine ArticleHighlights from this issue -
What Evolution Can Teach Us About Innovation
Innovation & Entrepreneurship Magazine ArticleMany people believe that the process for achieving breakthrough innovations is chaotic, random, and unmanageable. But that view is flawed, the authors... -
Addressing Demographic Disparities in Clinical Trials
R&D Digital ArticleWomen, people of color, and the elderly are often underrepresented in the data. -
The CEO of Pfizer on Developing a Vaccine in Record Time
Collaboration and teams Magazine ArticleIt started with a moon-shot challenge. -
White Coats, Black Scientists
Race Digital ArticleHow scientific institutions can address systemic racism. -
What It Takes to Lead a Disease Research Foundation
Leadership and managing people Digital ArticleThree strategies to stay laser focused on the path to a cure. -
Where Telemedicine Falls Short
Technology and analytics Digital ArticleIt offers enormous benefits — but can’t replace in-person visits. -
It’s Time for a New Kind of Electronic Health Record
Analytics and data science Digital ArticleWe need to shift from reactive to preventative care. -
How Medical Nonprofits Set Winning Strategy
Strategy Digital ArticleA study of nearly 100 organizations. -
Tilray's CEO on Becoming the First Mover in a Controversial Industry
Strategy & Execution Magazine ArticleThe author was working at a Silicon Valley bank in 2010 when some entrepreneurs pitched him on a "medical-cannabis technology company." He didn't know... -
3 Actions Congress Can Take to Reduce Drug Prices
Global Business Digital ArticleSaving patients money doesn't have to hurt business. -
Adopting AI in Health Care Will Be Slow and Difficult
Technology and analytics Digital ArticleA few key obstacles and how to overcome them. -
The Future of Drug Trials Is Better Data and Continuous Monitoring
R&D Digital ArticleIt will help patients and bring new treatments to market faster. -
3 Business Models That Could Bring Million-Dollar Cures to Everyone
Innovation Digital ArticleGene therapy is a medical breakthrough, but today it’s prohibitively expensive. -
Sexual Harassment Is Rampant in Health Care. Here’s How to Stop It.
Corporate governance Digital ArticleFive steps health organizations can take. -
Finding the Perfect Pace for Product Launches
Sales & Marketing Magazine ArticleWhat's the optimal number of new products to launch in a given time frame? Does it matter whether the launches are spread out or bunched together, and... - SPONSOR CONTENT FROM THE GOVERNMENT OF JAPAN
Why the Pharmaceutical Industry is Booming in Japan
Government policy and regulation Sponsor ContentOlder people need more medicine. That rule of life is no secret to pharmaceutical companies across the globe. Many also realize that Japan’s rapidly aging population presents a unique business opportunity. Japan remains the world’s second-biggest pharmaceuticals market, behind only the United States and China. The Japanese market also is expected to grow annually. […] -
“Businesses Exist to Deliver Value to Society.”
P&D Magazine ArticleA conversation with Merck CEO Kenneth Frazier
-
Nestlé Health Science: Building a healthy future towards 2030
Management Case Study11.95View Details The board of Nestlé S.A. announced that Anna Mohl would become the CEO of Nestlé Health Science (NHSc) - a global leader in nutritional science - on 1... -
Gavi and the "Next" Pandemic
Management Case Study11.95View Details In 2025, CEO Dr. Sania Nishtar and her team consider the lessons the Global Alliance for Vaccine and Immunizations (GAVI) learned from the pandemic. GAVI... -
Dan Doctoroff and the Power of Collaboration: Target ALS Accelerates the Race Against a Deadly Disease
Management Case Study11.95View Details The case study examines Dan Doctoroff, an innovative leader in the public and private sectors, and his efforts to turbo-charge philanthropy and find a... -
CVS Health in 2024: Navigating Challenging Times in a Changing Industry
Management Case Study11.95View Details CVS Health Corporation (CVS) had historically been one of the leading competitors in the retail pharmacy industry. Since its founding in 1963, the company... -
Myeloma Investment Fund
Management Case Study11.95View Details This case explores a critical decision facing the Myeloma Investment Fund (MIF) as it evaluates two investment opportunities aimed at accelerating a cure... -
Novo Nordisk Foundation
Management Case Study11.95View Details In 2024, Novo Nordisk A/S was one of the most profitable firms in the world, thanks largely to just two GLP-1-based drugs, Ozempic and Wegovy. Unusually,... -
De Dietrich: Globalisation of a Family Business
Management Case Study11.95View Details De Dietrich Process Systems (De Dietrich), a French pharmaceutical processing equipment company, was launched by the De Dietrich family whose business... -
ZS Associates: Research and Development Specialist (HANDOUT 3)
Management Case Study5.00View Details Handout for case UV8564 -
ZS Associates: Business Development Specialist (HANDOUT 1)
Management Case Study5.00View Details Handout for case UV8564 -
Expanscience's sustainability journey: Transformation toward a regenerative business model
Management Case Study11.95View Details Family-owned Laboratoires Expanscience with headquarters in Paris, established in 1950 is a significant player in the pharmaceutical and skincare industry.... -
ZS Associates: Marketing Manager (HANDOUT 2)
Management Case Study5.00View Details Handout for case UV8564 -
STADA: Sustaining agility and entrepreneurship in a fast-growing pharma company
Management Case Study11.95View Details Peter Goldschmidt became the CEO of pharmaceuticals company STADA in 2018. He was a firm believer in culture as a driving force - and a predictor - of... -
Lana Ghanem: Pushing the Boundaries of Health Care through Venture Capital
Management Case Study11.95View Details Lana Ghanem, managing director of Hikma Ventures, the corporate venture arm of larger pharmaceutical group Hikma, is considering how to grow the venture... -
Miravo Healthcare: Marketing Resultz
{{MajorSubject}} Case Study11.95View Details In August 2022, two interns at Miravo Healthcare (Miravo) needed to present a comprehensive marketing plan for Miravo's over-the-counter (OTC) head lice... -
Market Dynamics and Moral Dilemmas: Novo Nordisk's Weight-Loss Drugs
Management Case Study11.95View Details Danish pharmaceutical company Novo Nordisk was owned by a charitable foundation, and since its founding in the 1920s had focused on producing insulin... -
Moderna: Pioneering a People Platform to Accelerate Science Innovation
Management Case Study11.95View Details Moderna was founded in 2010 to explore how messenger ribonucleic acid (mRNA) could be used to create breakthrough medicines by encoding instructions for... -
WeightWatchers: Promoting Weight Health
Management Case Study11.95View Details In December 2023, the 60-year-old weight management industry stalwart WeightWatchers announced the launch of WeightWatchers Clinic, which incorporated... -
Easier Together: Zirq Solutions' Ecosystem Approach to Recycling Insulin Pens
Management Case Study11.95View Details The case describes how the Danish company Zirq Solutions, a subsidiary of Norwegian NG Group, brought circular economy thinking to the pharmaceutical... -
Compass Pathways: Pioneering Psychedelic Treatment
Management Case Study11.95View Details This case follows Compass Pathways, a pioneering company developing treatment for depression based on psilocybin, the compound found in 'magic mushrooms.'... -
Accounting Red Flags or Red Herrings at Catalent? (B)
Management Case Study5.00View Details GlassHouse Research identified accounting red flags at Catalent. Fiat Lux Partners countered most of GlassHouse's claims. Who was right? This update explores...
